Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 8-U.S. crude settles lower on worries about Coronavirus vaccine rollout

Fri, 29th Jan 2021 05:59

(New throughout, updates prices, market activity and comments
to settlement)

By Jessica Resnick-Ault

NEW YORK, Jan 29 (Reuters) - U.S. oil prices settled
slightly lower after trading in a tight range on Friday, as
investors worried about the lingering global pandemic and slow
vaccine rollouts.

The most active global Brent crude contract also
ended lower on concerns about vaccine distribution and the
efficacy of one vaccine.

"The vaccine numbers are just not there," said Bob Yawger,
director of energy futures at Mizuho in New York.

Oil markets have rallied about 50% since October on the back
of vaccine rollouts, but the emergence of COVID-19 variants has
fanned worries about economic weakness. Yawger said a U.S.
economic stimulus package may not come quickly enough to support
the market.

U.S. President Joe Biden urged Congress to take swift action
on a $1.9 trillion COVID-19 relief proposal.

"There is no time for any delays," Biden said. "It could
take a year longer to return to full employment if we don't act
and don't act now."

Global benchmark Brent crude futures for March
settled up 36 cents, or 0.6% a barrel, at $55.88. The Brent
March contract expires on Friday. The more active April contract
settled down 6 cents a barrel, at $55.04.

U.S. West Texas Intermediate (WTI) crude futures fell
14 cents, or 0.3%, to $52.20.

Both front-month Brent and WTI were on track to post a
weekly gain of less than 1%.

A Reuters poll showed oil prices are expected to hover
around current levels for much of 2021 before a recovery gains
traction towards year-end.

U.S. crude fell along with stock indexes, as investors
gauged the efficacy data of Johnson & Johnson's COVID-19
vaccine. The drugmaker's shares fell after it said its
single-dose vaccine was 72% effective in preventing COVID-19 in
the United States, with a lower rate of 66% observed globally.

Saudi Arabia is set to cut output by 1 million barrels per
day (bpd) in February and March. Compliance with output curbs by
the Organization of the Petroleum Exporting Countries and
allies, together known as OPEC+, improved in January.

OPEC oil output rose in January, a Reuters survey found,
after OPEC+ agreed to an easing of supply curbs.

However, the rise was less than the agreed amount, with an
involuntary drop in Nigerian exports limiting the increase.
(Reporting by Jessica Resnick-Ault in New York
Additional reporting by Bozorgmehr Sharafedin in London, Roslan
Khasawneh in Singapore and Sonali Paul in Melbourne
Editing by David Goodman, Louise Heavens, David Gregorio and
Richard Chang)

More News
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.